MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.30057

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2022

The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.

Cajigas Hector R, Kaptzan Tatiana, Lewis Bradley, El-Sabbagh Abdallah, Al-Hijji Mohammed, Eleid Mackram, Alkhouli Mohamad, Wang Dee Dee, Eng Marvin, Kodali Susheel, George Isaac, Chakravarty Tarun, Pershad Ashish, O'Hair Daniel, Jones Noah, Makkar Raj, Reisman Mark, Leon Martin, O'Neill William, Rihal Charanjit, Guerrero Mayra

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To assess the impact of pulmonary hypertension (PH) on outcomes of patients with severe mitral annular calcification (MAC) undergoing transcatheter mitral valve replacement (TMVR).

BACKGROUND

PH is associated with poor outcomes after mitral valve surgery. Whether the presence of PH in patients with MAC undergoing (TMVR) is associated with poor outcomes, is unknown.

METHODS

Retrospective evaluation of 116 patients from 51 centers in 11 countries who underwent TMVR with valve in mitral annular calcification (ViMAC) using balloon-expandable aortic transcatheter valves (THVs) from September 2012 to March 2017. Pulmonary artery systolic blood pressure (PASP) by echocardiogram was available in 90 patients. The subjects were stratified based on PASP: No PH = PASP ≤35 mmHg (n = 11); mild to moderate PH = PASP 36-49 mmHg (n = 21) and severe PH = PASP ≥50 mmHg (n = 58). Clinical, procedural, and echocardiographic outcomes were assessed.

RESULTS

Mean age was 72.7 (±12.8) years, 59 (65.6%) were female, Society of Thoracic Surgeons score was 15.8 + 11.8% and 90.0% where in New York Heart Association (NYHA) class III-IV. There was no significant difference in all-cause mortality at 30 days (no PH = 27.3%, mild-moderate PH = 19.0%, severe PH = 31.6%; p = 0.55) or at 1 year (no PH = 54.5%, mild-moderate PH = 38.1%, severe PH = 56.1%; p = 0.36). No difference in adverse events, NYHA class or amount of residual mitral regurgitation at 1 year were observed between the groups.

CONCLUSION

This study suggests that the presence of PH in patients with predominantly mitral stenosis with MAC undergoing TMVR does not impact mortality or adverse events. Further studies are needed to fully understand the effect of PH in this group of patients.

Для цитирования: Cajigas Hector R, Kaptzan Tatiana, Lewis Bradley, El-Sabbagh Abdallah, Al-Hijji Mohammed, Eleid Mackram, Alkhouli Mohamad, Wang Dee Dee, Eng Marvin, Kodali Susheel, George Isaac, Chakravarty Tarun, Pershad Ashish, O'Hair Daniel, Jones Noah, Makkar Raj, Reisman Mark, Leon Martin, O'Neill William, Rihal Charanjit, Guerrero Mayra. The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2022. DOI: 10.1002/ccd.30057.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.